Developing a treatment for Lassa fever virus
Task B06: PROCESS DEVELOPMENT AND SYNTHESIS OF A THERAPEUTIC FOR LASSA FEVER VIRUS
This study is working on developing a new treatment for Lassa fever, aiming to find safe and effective options that could help people who are affected by this serious illness.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sri International NIH-funded |
| Lab location | 1 site (Menlo Park, United States) |
| Project ID | NIH-11250785 on NIH RePORTER |
What this research studies
This research focuses on creating a therapeutic agent for Lassa fever virus, a serious infectious disease. The approach involves preclinical development, which includes planning, evaluating potential treatments, and conducting laboratory tests to assess safety and effectiveness. Researchers will identify promising compounds and manufacture them under strict quality standards, followed by testing in both laboratory and animal models to understand how the treatment works and its potential side effects.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of Lassa fever infection or those who have been diagnosed with the virus.
Not a fit: Patients with other viral infections or those not at risk for Lassa fever may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to an effective treatment for Lassa fever, improving outcomes for patients infected with the virus.
How similar studies have performed: While there have been efforts to develop treatments for Lassa fever, this specific approach is part of ongoing research and may offer novel insights into effective therapies.
Where this research is happening
Menlo Park, United States
- Sri International — Menlo Park, United States (Active)
Researchers
- Principal investigator: Mirsalis, Jon — Sri International
- Study coordinator: Mirsalis, Jon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.